Vrushabh P. Ladage, BS

Articles by Vrushabh P. Ladage, BS

Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of "Too Much Too Soon"

ByJalpa A. Doshi, PhD,Pengxiang Li, PhD,Amy R. Pettit, PhD,J. Samantha Dougherty, PhD,Ashley Flint, MPP,Vrushabh P. Ladage, BS

March 17th 2017

Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.

Impact of Cost Sharing on Specialty Drug Utilization and Outcomes: A Review of the Evidence and Future Directions

ByJalpa A. Doshi, PhD,Pengxiang Li, PhD,Vrushabh P. Ladage, BS,Amy R. Pettit, PhD,Erin A. Taylor, PhD, MSPH

March 17th 2016

The authors review published evidence regarding associations between high cost sharing for specialty pharmaceuticals indicated for rheumatoid arthritis, multiple sclerosis, and cancer, and their utilization.

Vrushabh P. Ladage, BS

Articles by Vrushabh P. Ladage, BS

Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of "Too Much Too Soon"

Impact of Cost Sharing on Specialty Drug Utilization and Outcomes: A Review of the Evidence and Future Directions

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access